GSK (GSK) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free GSK Stock Alerts $44.24 -0.88 (-1.95%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 9:28 AM | marketbeat.comHsbc Holdings PLC Acquires Shares of 2,495,096 GSK plc (NYSE:GSK)Hsbc Holdings PLC acquired a new position in shares of GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,495,096 shares of the pharmaceutical company's stock, valued at approximatelyMay 28 at 3:05 AM | seekingalpha.comGSK plc: Long-Term Cash CowMay 27 at 6:01 PM | stocknews.comTop 4 Pharma Stocks for Long-Term Value Investors in 2024May 27 at 4:51 AM | marketbeat.comDimensional Fund Advisors LP Increases Stock Position in GSK plc (NYSE:GSK)Dimensional Fund Advisors LP grew its position in GSK plc (NYSE:GSK - Free Report) by 1.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,777,695 shares of the pharmaceutical company's stock after pMay 27 at 1:20 AM | americanbankingnews.comGSK plc (NYSE:GSK) Receives Consensus Rating of "Hold" from BrokeragesMay 27 at 1:19 AM | marketbeat.comGSK plc (NYSE:GSK) Given Consensus Recommendation of "Hold" by AnalystsGSK plc (NYSE:GSK - Get Free Report) has earned a consensus rating of "Hold" from the five ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three havMay 25, 2024 | americanbankingnews.comQ2 2024 EPS Estimates for GSK plc Lowered by Analyst (NYSE:GSK)May 25, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Bought by Primecap Management Co. CAPrimecap Management Co. CA grew its holdings in GSK plc (NYSE:GSK - Free Report) by 0.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,089,370 shares of the pharmaceutical company'sMay 24, 2024 | msn.comGSK wins US personal injury case over Zantac useMay 24, 2024 | marketbeat.comQ2 2024 EPS Estimates for GSK plc Decreased by Zacks Research (NYSE:GSK)GSK plc (NYSE:GSK - Free Report) - Investment analysts at Zacks Research cut their Q2 2024 earnings per share estimates for GSK in a research report issued on Wednesday, May 22nd. Zacks Research analyst E. Bagri now expects that the pharmaceutical company will post earnings of $1.00 per share forMay 24, 2024 | americanbankingnews.comGSK plc (NYSE:GSK) to Post Q3 2024 Earnings of $1.25 Per Share, Zacks Research ForecastsMay 23, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Purchased by Trexquant Investment LPTrexquant Investment LP lifted its stake in GSK plc (NYSE:GSK - Free Report) by 1,710.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 121,746 shares of the pharmaceutical company's stock after purchasing an additional 115,022 shares duMay 23, 2024 | marketbeat.comZacks Research Weighs in on GSK plc's Q3 2024 Earnings (NYSE:GSK)GSK plc (NYSE:GSK - Free Report) - Research analysts at Zacks Research upped their Q3 2024 earnings per share (EPS) estimates for GSK in a research note issued to investors on Wednesday, May 22nd. Zacks Research analyst E. Bagri now expects that the pharmaceutical company will earn $1.25 per sharMay 22, 2024 | msn.comGSK succeeds in late-stage trials for asthma candidateMay 22, 2024 | marketbeat.comJPL Wealth Management LLC Purchases New Position in GSK plc (NYSE:GSK)JPL Wealth Management LLC acquired a new position in GSK plc (NYSE:GSK - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 30,461 shares of the pharmaceutical company's stock, valued at approximately $1May 22, 2024 | seekingalpha.comGSK Breathes New Life Into Asthma Treatment With DepemokimabMay 21, 2024 | marketbeat.comBard Financial Services Inc. Has $1.52 Million Stock Holdings in GSK plc (NYSE:GSK)Bard Financial Services Inc. grew its stake in shares of GSK plc (NYSE:GSK - Free Report) by 491.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 41,045 shares of the pharmaceutical company's stock after buying an additional 34,100 shMay 21, 2024 | finance.yahoo.comGSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest TrialMay 21, 2024 | reuters.comGSK's asthma drug shows promise in reducing severe attacksMay 21, 2024 | reuters.comGSK's asthma drug shows promise in reducing severe attacksMay 20, 2024 | marketbeat.comBrandes Investment Partners LP Has $39.48 Million Holdings in GSK plc (NYSE:GSK)Brandes Investment Partners LP lifted its position in GSK plc (NYSE:GSK - Free Report) by 55.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,065,333 shares of the pharmaceutical company's stock afteMay 20, 2024 | finance.yahoo.comGSK whistleblower claims drugmaker cheated US government over Zantac cancer riskMay 20, 2024 | reuters.comGSK faces whistleblower lawsuit over Zantac cancer riskMay 19, 2024 | marketbeat.comArjuna Capital Takes $1.16 Million Position in GSK plc (NYSE:GSK)Arjuna Capital bought a new position in shares of GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 31,253 shares of the pharmaceutical company's stock, valued at approxiMay 18, 2024 | marketbeat.comGSK plc (NYSE:GSK) is Equity Investment Corp's 5th Largest PositionEquity Investment Corp reduced its position in GSK plc (NYSE:GSK - Free Report) by 1.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,243,259 shares of the pharmaceutical company's stock after sellinMay 17, 2024 | finance.yahoo.comGSK to divest remaining 4.2% stake in HaleonMay 17, 2024 | msn.comGSK completes sale of Haleon shares having raised £3.9bn since IPOMay 17, 2024 | bloomberg.comGSK to Sell Remaining $1.6 Billion Stake in HaleonMay 17, 2024 | thetimes.co.ukGSK sells remaining stake in Haleon for £1.2bnMay 17, 2024 | msn.comGSK raises $1.5 billion from sale of remaining Haleon stakeMay 17, 2024 | lse.co.ukLONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stakeMay 17, 2024 | marketwatch.comGSK Sells Last Haleon Shares for $1.58 BlnMay 17, 2024 | msn.comGSK raises £1.25bn as it offloads final stake in HaleonMay 17, 2024 | msn.comGSK raises $1.5 billion from offloading Haleon stake at a discountMay 17, 2024 | reuters.comGSK raises $1.5 bln from offloading Haleon stake at a discountMay 16, 2024 | ft.comGSK sells off remaining stake in HaleonMay 16, 2024 | reuters.comGSK intends to sell its remaining stake in HaleonMay 15, 2024 | msn.comGSK goes ex dividend tomorrowMay 15, 2024 | marketbeat.com216,942 Shares in GSK plc (NYSE:GSK) Bought by Moran Wealth Management LLCMoran Wealth Management LLC purchased a new stake in GSK plc (NYSE:GSK - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 216,942 shares of the pharmaceutical company's stock, valued aMay 13, 2024 | marketbeat.comQRG Capital Management Inc. Grows Stock Position in GSK plc (NYSE:GSK)QRG Capital Management Inc. boosted its stake in GSK plc (NYSE:GSK - Free Report) by 20.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 141,414 shares of the pharmaceutical company's stock after acquiringMay 11, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Sold by Lincluden Management Ltd.Lincluden Management Ltd. decreased its position in GSK plc (NYSE:GSK - Free Report) by 61.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 65,975 shares of the pharmaceutical company's stock aftMay 11, 2024 | finance.yahoo.comGSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four DaysMay 10, 2024 | marketbeat.comInvestors Buy High Volume of GSK Call Options (NYSE:GSK)GSK plc (NYSE:GSK - Get Free Report) was the recipient of some unusual options trading on Friday. Stock traders purchased 16,167 call options on the company. This represents an increase of 238% compared to the average daily volume of 4,784 call options.May 8, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Purchased by Natixis Advisors L.P.Natixis Advisors L.P. boosted its position in shares of GSK plc (NYSE:GSK - Free Report) by 10.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 325,676 shares of the pharmaceutical company's stock after acquiMay 7, 2024 | msn.comGSK expands collaboration with BioVersys on tuberculosis asset alpibectirMay 7, 2024 | globenewswire.comBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionMay 6, 2024 | msn.comGenomics plc and GSK collaborate to harness polygenic risk scores in clinical trialsMay 4, 2024 | marketbeat.comGSK plc (NYSE:GSK) Shares Sold by Raymond James Financial Services Advisors Inc.Raymond James Financial Services Advisors Inc. lowered its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 11.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 259,953 shares of the pharmaceuticalMay 3, 2024 | marketbeat.comFisher Asset Management LLC Raises Position in GSK plc (NYSE:GSK)Fisher Asset Management LLC boosted its position in GSK plc (NYSE:GSK - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 15,065,558 shares of the pharmaceutical company's stock after acqMay 2, 2024 | msn.comGSK, Boehringer Put Profits Over Safety, Zantac Jury Told Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump. Click here to see why it will be ______ _________. GSK Media Mentions By Week GSK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.590.79▲Average Medical News Sentiment GSK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼2311▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bristol-Myers Squibb News Today Zoetis News Today Regeneron Pharmaceuticals News Today Vertex Pharmaceuticals News Today Sanofi News Today Takeda Pharmaceutical News Today Pfizer News Today Abbott Laboratories News Today Novartis News Today AstraZeneca News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 5/29/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
